The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.

Say goodbye to the classic ClinicalTrials.gov!

The classic ClinicalTrials.gov website will be retired on June 25, 2024. Please use the modernized ClinicalTrials.gov. For more information, see ClinicalTrials.gov Modernization.

Key Record Dates

ClinicalTrials.gov Identifier:	NCT05644561
Brief Title:	Evaluation of Pharmacokinetics, Pharmacodynamics, Efficacy, Safety, and Immunogenicity of Ravulizumab Administered Intravenously in Pediatric Participants With Generalized Myasthenia Gravis (gMG)

First Submitted :	December 1, 2022
First Submitted that Met QC Criteria :	December 1, 2022
First Posted :	December 9, 2022

Last Update Submitted that Met QC Criteria :	March 25, 2024
Last Update Posted :	March 26, 2024

To Top